Growth Metrics

Innoviva (INVA) Non-Current Deffered Revenue (2010 - 2017)

Innoviva posted quarterly Non-Current Deffered Revenue of $1.6 million for Q3 2017, down 36.3% year-on-year from $2.4 million in Q3 2016, and down 12.47% on a QoQ basis from $1.8 million in Q2 2017.

Innoviva (INVA) has 8 years of Non-Current Deffered Revenue data on file, last reported at $1.6 million in Q3 2017.

  • For the quarter ending Q3 2017, Non-Current Deffered Revenue fell 36.3% year-over-year to $1.6 million; the trailing twelve-month figure through Sep 2017 stood at $1.6 million (down 36.3% YoY), and the FY2016 full-year result was $2.2 million, down 28.56% from the prior year.
  • Non-Current Deffered Revenue for Q3 2017 stood at $1.6 million, down from $1.8 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $5.7 million in Q1 2013 and bottomed at $100000.0 in Q3 2015.
  • The 5-year median for Non-Current Deffered Revenue is $3.1 million (2015), against an average of $3.2 million.
  • The widest annual swing landed in 2015, when Non-Current Deffered Revenue plunged 97.64%; it then jumped 2503.92% in 2016.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $5.5 million in 2013, then plunged by 30.56% to $3.8 million in 2014, then dropped by 18.19% to $3.1 million in 2015, then slipped by 28.56% to $2.2 million in 2016, then fell by 29.95% to $1.6 million in 2017.
  • The last three Non-Current Deffered Revenue figures came in at $1.6 million (Q3 2017), $1.8 million (Q2 2017), and $2.0 million (Q1 2017), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 225.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2017 1.55 Mn
Jun 30, 2017 1.77 Mn
Mar 31, 2017 1.99 Mn
Dec 31, 2016 2.21 Mn
Sep 30, 2016 2.44 Mn
Jun 30, 2016 2.66 Mn
Mar 31, 2016 2.88 Mn
Dec 31, 2015 3.10 Mn
Sep 30, 2015 100,000.00
Jun 30, 2015 102,000.00
Mar 31, 2015 3.76 Mn
Dec 31, 2014 3.79 Mn
Sep 30, 2014 4.06 Mn
Jun 30, 2014 4.33 Mn
Mar 31, 2014 4.89 Mn
Dec 31, 2013 5.46 Mn
Sep 30, 2013 4.66 Mn
Jun 30, 2013 4.70 Mn
Mar 31, 2013 5.67 Mn
Dec 31, 2012 6.01 Mn
Sep 30, 2012 5.79 Mn
Jun 30, 2012 5.48 Mn
Mar 31, 2012 7.84 Mn
Dec 31, 2011 122.02 Mn
Sep 30, 2011 124.44 Mn
Jun 30, 2011 127.39 Mn
Dec 31, 2010 137.43 Mn